Is Spotify a Millionaire-Maker Stock?
Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…
Sell
34
SLRX Quote, Financials, Valuation and Earnings
Last price:
$0.78
Seasonality move
:
-13.99%
Day range:
$0.76 - $0.80
52-week range:
$0.45 - $7.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.09x
Volume:
23K
Avg. volume:
183.3K
1-year change:
-81.01%
Market cap:
$1.6M
Revenue:
--
EPS (TTM):
-$7.43
Earnings Data
Next earnings date for SLRX
Aug 08
2025
Most recent earnings per share
-$1.02
Missed by $1.02
(Mar 24/2025)
Consensus Estimate
--
(Mar 24/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SLRX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/24/2025 | Q4 | -- | -- | -$1.02 | -- | -- |
| 11/14/2024 | Q3 | -- | -- | -$0.76 | -$53.60 | $52.84 |
| 08/09/2024 | Q2 | -- | -- | -$2.37 | -$53.60 | $51.23 |
| 04/25/2024 | Q1 | -- | -- | -$3.28 | -$53.60 | $50.32 |
| 03/22/2024 | Q4 | -- | -- | -$0.03 | -- | -- |
| 11/09/2023 | Q3 | -- | -- | -$5.21 | -$9.60 | $4.39 |
| 06/30/2023 | Q2 | -- | -- | -$11.45 | -$10.37 | -$1.08 |
| 03/31/2023 | Q1 | -- | -- | -$17.84 | -$20.00 | $2.16 |
| 12/31/2022 | Q4 | -- | -- | -$22.00 | -$16.56 | -$5.44 |
| 11/04/2022 | Q3 | -- | -- | -$51.28 | -$20.40 | -$30.88 |
| 08/05/2022 | Q2 | -- | -- | -$17.60 | -- | -- |
| 05/12/2022 | Q1 | -- | -- | -$26.40 | -- | -- |
| 03/18/2022 | Q4 | -- | -$1.8M | -$18.00 | -- | -- |
| 11/04/2021 | Q3 | -- | -- | -$16.72 | -- | -- |
| 08/05/2021 | Q2 | -- | $571.4K | -$14.00 | -- | -- |
| 05/12/2021 | Q1 | -- | $1.3M | -$12.00 | -- | -- |
| 03/18/2021 | Q4 | -- | -$3.8M | -$20.00 | -- | -- |
| 09/30/2020 | Q3 | -- | $1.4M | -$20.00 | -- | -- |
| 06/30/2020 | Q2 | -- | $1.2M | -$26.00 | -- | -- |
| 03/31/2020 | Q1 | -- | $1.1M | -$44.00 | -- | -- |
| 12/31/2019 | Q4 | -- | $1M | -$88.00 | -- | -- |
| 09/30/2019 | Q3 | -- | $875K | -$146.00 | -- | -- |
| 06/30/2019 | Q2 | -- | $895.8K | -$60.00 | -- | -- |
| 03/31/2019 | Q1 | -- | $105K | -$600.00 | -- | -- |
| 12/31/2018 | Q4 | -- | $163.1K | -$550.00 | -- | -- |
| 11/06/2018 | Q3 | -- | $251K | -$750.00 | -- | -- |
| 08/01/2018 | Q2 | -- | $245.5K | -$2,500.00 | -- | -- |
| 05/02/2018 | Q1 | -- | $178.6K | -$2,300.00 | -- | -- |
| 03/07/2018 | Q4 | -- | $282.8K | -$2,300.00 | -- | -- |
| 11/06/2017 | Q3 | -- | $413.6K | -$2,700.00 | -- | -- |
| 08/02/2017 | Q2 | -- | $335.5K | -$2,550.00 | -- | -- |
| 05/03/2017 | Q1 | -- | $242.6K | -$2,450.00 | -- | -- |
| 03/08/2017 | Q4 | -- | $298.9K | -$2,400.00 | -- | -- |
| 09/30/2016 | Q3 | -- | $599.1K | -$3,250.00 | -- | -- |
| 06/30/2016 | Q2 | -- | $112.7K | -$3,550.00 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$3,050.00 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$2,550.00 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$2,650.00 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | -$2,350.00 | -- | -- |
Salarius Pharmaceuticals Earnings Questions
-
How Much did Salarius Pharmaceuticals Generate in Revenue Last Quarter?
Salarius Pharmaceuticals reported -- worth of top line sales in its most recent quarter.
-
Did Salarius Pharmaceuticals Beat Earnings Last Quarter?
Salarius Pharmaceuticals announced earnings per share of -$1.02 which represents a miss of analyst forecast a -- per share.
-
Is Salarius Pharmaceuticals Profitable?
Salarius Pharmaceuticals reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Salarius Pharmaceuticals EPS Next Year?
Salarius Pharmaceuticals's earnings are forecast to decrease from -$5.79 per share to -- per share next year representing a decrease of -597.72%.
-
When is Salarius Pharmaceuticals's Earnings Date?
Salarius Pharmaceuticals's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Is a Millionaire-Maker Stock?
From time to time, investors will run across the term…
5 Investors to Follow Other Than Warren Buffett
There is no doubt that Warren Buffett is one of…
Stock Ideas
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 10
Regencell Bioscience Holdings [RGC] is up 79.25% over the past day.
Buy
97
NGVC alert for May 10
Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.
Sell
38
ONTO alert for May 10
Onto Innovation [ONTO] is down 30.17% over the past day.
